Cell based metabolic barriers to glucose diffusion: Macrophages and continuous glucose monitoring

Biomaterials

Volumn 35, Issue 10, 2014, Pages 3145-3153

  Klueh, Ulrike ^a   Frailey, Jackman T ^a   Qiao, Yi ^a   Antar, Omar ^a   Kreutzer, Donald L ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Continuous glucose monitoring; Diabetes; Glucose metabolism; Implantable glucose sensor; Macrophages

Indexed keywords

GLUCOSE SENSORS; MACROPHAGES; MEDICAL PROBLEMS; METABOLISM; TISSUE;

CONTINUOUS GLUCOSE MONITORING; CONTINUOUS GLUCOSEMONITORING (CGM); GLUCOSE METABOLISM; IMPLANTABLE GLUCOSE SENSOR; IMPLANTATION SITES; INTERSTITIAL TISSUES; METABOLIC ACTIVITY; SENSOR PERFORMANCE;

GLUCOSE;

GLUCOSE; OXYGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; CELL COUNT; CONTINUOUS GLUCOSE MONITORING; CONTROLLED STUDY; DIFFUSION; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIUM; LYMPHOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE REACTION;

CONTINUOUS GLUCOSE MONITORING; DIABETES; GLUCOSE METABOLISM; IMPLANTABLE GLUCOSE SENSOR; MACROPHAGES;

ANIMALS; BIOSENSING TECHNIQUES; DIFFUSION; GLUCOSE; MACROPHAGES; MICE; MICE, INBRED C57BL;

EID: 84893684433     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.01.001     Document Type: Article

References (21)

1. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20(2):86-100.
2. Klueh U., Liu Z., Feldman B., Henning T.P., Cho B., Ouyang T., et al. Metabolic biofouling of glucose sensors in vivo: role of tissue microhemorrhages. J Diabetes Sci Technol 2011, 5(3):583-595.
3. Klueh U., Liu Z., Ouyang T., Cho B., Feldman B., Henning T.P., et al. Blood-induced interference of glucose sensor function in vitro: implications for in vivo sensor function. J Diabetes Sci Technol 2007, 1(6):842-849.
4. Novak M.T., Yuan F., Reichert W.M. Predicting glucose sensor behavior in blood using transport modeling: relative impacts of protein biofouling and cellular metabolic effects. J Diabetes Sci Technol 2013, 7(6):1547-1560.
5. Klueh U., Qiao Y., Frailey J.T., Kreutzer D.L. Impact of macrophage deficiency and depletion on continuous glucose monitoring in vivo. Biomaterials 2014, 35(6):1789-1796.
6. Mills C.D. M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol 2012, 32(6):463-488.
7. Feldman B., Brazg R., Schwartz S., Weinstein R. A continuous glucose sensor based on wired enzyme technology - results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 2003, 5(5):769-779.
8. Gerritsen M., Jansen J.A., Lutterman J.A. Performance of subcutaneously implanted glucose sensors for continuous monitoring. Neth J Med 1999, 54(4):167-179.
9. Klueh U., Liu Z., Cho B., Ouyang T., Feldman B., Henning T.P., et al. Continuous glucose monitoring in normal mice and mice with prediabetes and diabetes. Diabetes Technol Ther 2006, 8(3):402-412.
10. Macrophages 2000, Oxford University Press, Oxford New York. D.M. Paulnock (Ed.).
11. Patton S.R., Clements M.A. Average daily risk range as a measure for clinical research and routine care. J Diabetes Sci Technol 2013, 7(5):1370-1375.
12. Dailey G. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes. Clin Ther 2011, 33(6):665-678.
13. Klonoff D.C. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005, 28(5):1231-1239.
14. Klonoff D.C. The benefits of implanted glucose sensors. J Diabetes Sci Technol 2007, 1(6):797-800.
15. Desalvo D.J., Keith-Hynes P., Peyser T., Place J., Caswell K., Wilson D.M., et al. Remote glucose monitoring in camp setting reduces the risk of prolonged nocturnal hypoglycemia. Diabetes Technol Ther 2014 Jan, 16(1):1-7. http://dx.doi.org/10.1089/dia.2013.0139. [Epub 2013 Oct 29].
16. Hoss U, Jeddi I, Schulz M, Budiman E, Bhogal C, McGarraugh G. Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study. Diabetes Technol Ther;12(8):591-7.
17. Klueh U., Antar O., Qiao Y., Kreutzer D.L. Role of vascular networks in extending glucose sensor function: impact of angiogenesis and lymphangiogenesis on continuous glucose monitoring in vivo. J Biomed Mater Res Part A 2013 Nov 6, http://dx.doi.org/10.1002/jbm.a.35031. [Epub ahead of print].
18. Klueh U., Antar O., Qiao Y., Kreutzer D.L. Role of interleukin-1/interleukin-1 receptor antagonist family of cytokines in long-term continuous glucose monitoring in vivo. J Diabetes Sci Technol 2013, 7(6):1538-1546.
19. Koh A., Nichols S.P., Schoenfisch M.H. Glucose sensor membranes for mitigating the foreign body response. J Diabetes Sci Technol 2011, 5(5):1052-1059.
20. Roberts J.R., Park J., Helton K., Wisniewski N., McShane M.J. Biofouling of polymer hydrogel materials and its effect on diffusion and enzyme-based luminescent glucose sensor functional characteristics. J Diabetes Sci Technol 2012, 6(6):1267-1275.
21. Gerritsen M., Jansen J.A., Kros A., Vriezema D.M., Sommerdijk N.A., Nolte R.J., et al. Influence of inflammatory cells and serum on the performance of implantable glucose sensors. J Biomed Mater Res 2001, 54(1):69-75.